|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03320 CHINARES PHARMA
Nominal 
4.570 -0.040 (-0.868%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
8
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 64.00 RMB (cts) | |
| Net Profit | 4,045.47 RMB (MIL) | DPS | 19.40 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 4,261.50 | 67.70 | 18.60 | -- | 4,462.00 | 3,514.00 |
| 2027 | 4,582.35 | 73.45 | 19.85 | -- | 4,909.00 | 4,141.00 |
| 2028 | 4,761.83 | 73.25 | 21.00 | -- | 5,175.00 | 4,261.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 4,449.00 | 70.81 | -- | NOMURA | Buy | 7.52 | 26/03/2026 | |
| 2026 | 4,435.79 | 60.57 | 21.45 | MORGAN STANLEY | Overweight | 7.20 | 26/08/2026 | |
| 2026 | 4,462.00 | 71.00 | 21.00 | CICC | Outperform | 7.00 | 26/03/2026 | |
| 2026 | 4,263.00 | 68.00 | 20.00 | UBS | Buy | 6.90 | 25/03/2026 | |
| 2026 | 4,245.00 | 67.60 | 20.30 | CLSA | OutPerform | 6.50 | 26/08/2026 | |
| 2026 | 3,514.00 | 62.00 | 11.00 | CHINA MERCHANTS | Buy | 6.30 | 26/08/2026 | |
| 2026 | 3,995.00 | 64.00 | 12.98 | HAITONG | OutPerform | 5.93 | 24/08/2026 | |
| 2026 | 4,260.00 | 67.80 | 17.20 | BANK OF AMERICA | Buy | 5.70 | 25/08/2026 | |
| 2027 | 4,764.00 | 75.83 | -- | NOMURA | -- | -- | 26/03/2026 | |
| 2027 | 4,667.71 | 64.04 | 22.24 | MORGAN STANLEY | -- | -- | 26/08/2026 | |
| 2027 | 4,909.00 | 78.00 | 24.00 | CICC | -- | -- | 26/03/2026 | |
| 2027 | 4,497.00 | 72.00 | 22.00 | UBS | -- | -- | 25/03/2026 | |
| 2027 | 4,327.00 | 68.90 | 20.70 | CLSA | -- | -- | 26/08/2026 | |
| 2027 | 4,303.00 | 76.00 | 13.00 | CHINA MERCHANTS | -- | -- | 26/08/2026 | |
| 2027 | 4,141.00 | 66.00 | 12.98 | HAITONG | -- | -- | 24/08/2026 | |
| 2027 | 4,705.00 | 74.90 | 19.00 | BANK OF AMERICA | -- | -- | 25/08/2026 | |
| 2028 | 4,738.66 | 64.90 | 22.64 | MORGAN STANLEY | -- | -- | 26/08/2026 | |
| 2028 | 4,785.00 | 76.00 | 23.00 | UBS | -- | -- | 25/03/2026 | |
| 2028 | 4,429.00 | 70.50 | 21.10 | CLSA | -- | -- | 26/08/2026 | |
| 2028 | 4,856.00 | 86.00 | 15.00 | CHINA MERCHANTS | -- | -- | 26/08/2026 | |
| 2028 | 4,261.00 | 68.00 | 12.98 | HAITONG | -- | -- | 24/08/2026 | |
| 2028 | 5,175.00 | 82.40 | 20.90 | BANK OF AMERICA | -- | -- | 25/08/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 28/08/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,186,632 |
| %Change | 5.264% |
| EPS / (LPS) | RMB 0.350 |
| NBV Per Share (¥) | RMB 8.404 |